55
DAFTAR PUSTAKA
Al-Qur’an dan Terjemah cetakan ke-10, 2006. Departemen Agama RI, Bandung.
Penerbit Diponegoro
Abad VC and Guillmninault, C. 2017. New Developments in the Management of Narcolepsy, p. 39-57
Abad VC and Guilleminault C. 2004. Review of rapid eye movement behavior sleep disorders. Curr Neurol Neurosci Rep. 4(2):157-63.
Adib, A. 2016. Allah menurunkan penyakit dan obatnya.
http://alkarimah.or.id/allah-menurunkan-penyakit-dan-obatnya/. Diakses 9 Mei 2018.
Alberto, K. et al. 2013. CD4 + T Cell Autoimmunity to Hypocretin / Orexin and Cross-Reactivity to a 2009 H1N1 Influenza A Epitope in Narcolepsy, 176.
Alfadhli, Laili. 2015. Sakit dalam Pandangan Islam. www.kompasiana.com.
Diakses 10 Mei 2018
Billiard, M., Dauvilliers, Y., Gro, L. D., Lammers, G. J., Mayer, G., & Sonka, K.
2011. Management of narcolepsy in a dults. European Handbook of Neurological Management, 1, 513–528.
Black, J., & Houghton, W. C. 2006. Sodium Oxybate Improves Excessive Daytime Sleepiness in Narcolepsy, 29.
Black, J., Swick, T., Bogan, R., Lai, C., & Carter, L. P. 2016. Impact of sodium oxybate , modafinil , and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Sleep Medicine, 24, 57–62.
Bozorg, AM. 2015. Narcolepsy (online), Medscape Reference.
http://emedicine.medscape.com/article/1188433-overview. Diakses tanggal 15 Mei 2018.
Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF. 1997.
Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.
Neurology.;49:444–51.
Burgess CR, Scammell TE. 2012. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci. 32(36):12305-11
Cephalon, Inc. 2010. Provigil(modafinil) tablets prescribing information. Frazer, PA.
Fahmi M. 2011. Penulis As-Sa’di di dalam : Al-Mumti’ Fi al-Qawa’id al- Fiqhiyyah, Riyadh Saudi Arabia: Dar Zidnie, Cetakan pertama, hal. 141
56 Huang YS, Guilleminault C. 2009. Narcolepsy: action of two gammaaminobutyric acid type B agonists, baclofen and sodium oxybate.
Pediatr Neurol; 41:9–16.
Kothare, S. V, & Kaleyias, J. 2010. Clinical Medicine Insights : Therapeutics Pharmacotherapy of Narcolepsy : Focus on Sodium Oxybate. Libertas Academica, 37–52.
Lecendreux et al. 2012. Modafinil and paediatric narcolepsy Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy, 481–483.
Leschziner, G. 2014. Narcolepsy : a clinical review, 323–331.
Mayer, G. 2012. The use of sodium oxybate to treat narcolepsy, 12(5), 519–529.
Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al.
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002 Oct. 59(10):1553- 62.
Mohammad Al Munajjed. 2016. https://islamqa.info/id/112905. Diakses 11 mei 2018.
Morgenthaler, T. I., Kapur, V. K., Brown, T. M., Swick, T. J., Alessi, C., Aurora, R. N., Zak, R. 2007. Practice Parameters for the Treatment of Narcolepsy and other Hypersomnias of Central Origin.
MUI. 2013. Fatwa Majelis Ulama Indonesia Tentang Obat dan Pengobatan.
www.mui.or.id. Diakses 10 Mei 2018.
Mustafa. 2017. Makalah Pengobatan Menggunakan Zat yang Haram.
https://mustafatanjong.blogspot.co.id/2017/01/makalah-pengobatan- menggunakan-zat-yang.html. Diakses 11 Mei 2018.
Nallu, S. 2017. Narcolepsy. Medscape Reference.
https://emedicine.medscape.com/article/1188433-overview. Diakses 10 Mei 2018.
Naumann, A., & Daum, I. 2003. Narcolepsy : Pathophysiology and neuropsychological changes, 14, 89–98.
NCBI. 2014. Narcolepsy.
https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0062956/. Diakses 14 Mei 2018.
Nishino S, Okuro M, Kotorii N, et al. 2010. Hypocretin/Orexin and Narcolepsy Narcolepsy New Basic and Clinical Insight. Acta Physiol (Oxf); 198(3):
209.
Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K. 2009.
Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep. 32(2):175-80
57 Robertson P and Hellriegel ET. 2003. Clinical Pharmacokinetic Profile of
Modafinil. USA :Adis International Limited.
Roth, T., Ph, D., Dauvilliers, Y., Mignot, E., Ph, D., Montplaisir, J., & Ph, D.
2013. disrupted Nighttime sleep in Narcolepsy, 9(9), 15–18.
Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M, et al.
2010. An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet. 128(4):433-41.
Swanson J, Baler RD, Volkow ND. 2011. Understanding the effects of stimulant medications on cognition in individuals with attentiondeficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology; 36:207–26.
Tausikal, MA. 2013. Memilih Berobat atau Bersabar dan Tawakal ? https://rumaysho.com/5136-memilih-berobat-atau-sabar-dan-
tawakkal.html
Thannickal TC, Nienhuis R, Siegel JM. 2009. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep. 32(8):993-8.
Tjan T et al. 2007. Obat-obat penting, Jakarta: Elex Media Komputindo.
Van Brunt DL, Johnston JA, Ye W, Pohl GM, Sun PJ, Sterling KL, Davis ME.
2005. Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder. Pharmacotherapy; 2511:1541–9.
Zeman A, et al. 2004. Clinical Review Narcolepsy and Excessive Daytime Sleepiness, p. 724-8
Zuhroni. 2010. Pandangan Islam terhadap masalah kedokteran dan kesehatan.
Jakarta: Bagian Agama Universitas YARSI.
